Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Elevated Mutational Age in Blood of Children Treated for Cancer Contributes to Therapy-Related Myeloid Neoplasms
Eline J.M. Bertrums, Axel Rosendahl Huber, Jurrian K. de Kanter, et al.
Cancer Discovery (2022), pp. OF1-OF14
Open Access | Times Cited: 23

Showing 23 citing articles:

Dynamics of Age- versus Therapy-Related Clonal Hematopoiesis in Long-term Survivors of Pediatric Cancer
Kohei Hagiwara, Sivaraman Natarajan, Zhaoming Wang, et al.
Cancer Discovery (2023) Vol. 13, Iss. 4, pp. 844-857
Open Access | Times Cited: 29
Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures
Benjamin Diamond, Bachisio Ziccheddu, Kylee Maclachlan, et al.
Blood (2023)
Closed Access | Times Cited: 26
Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms
Eline J.M. Bertrums, Jurrian K. de Kanter, Lucca L.M. Derks, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues
Mònica Sánchez-Guixé, Ferran Muiños, Morena Pinheiro-Santin, et al.
Cancer Discovery (2024) Vol. 14, Iss. 6, pp. 953-964
Open Access | Times Cited: 6
Common anti-cancer therapies induce somatic mutations in stem cells of healthy tissue
Ewart Kuijk, Onno Kranenburg, Edwin Cuppen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Transient Differentiation-State Plasticity Occurs During Acute Lymphoblastic Leukemia Initiation
Vera M. Poort, Rico Hagelaar, Markus J. van Roosmalen, et al.
Cancer Research (2024) Vol. 84, Iss. 16, pp. 2720-2733
Open Access | Times Cited: 2
Distinct landscape and clinical implications of therapy-related clonal hematopoiesis
Koichi Takahashi, Daisuke Nakada, Margaret A. Goodell
Journal of Clinical Investigation (2024) Vol. 134, Iss. 19
Closed Access | Times Cited: 2
Genetic and epigenetic bases of long-term adverse effects of childhood cancer therapy
Zhaoming Wang, Jinghui Zhang
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 2
Single‐cell RNA sequencing of pediatric Hodgkin lymphoma to study the inhibition of T cell subtypes
Jurrian K. de Kanter, Alexander S. Steemers, Daniel Montiel Gonzalez, et al.
HemaSphere (2024) Vol. 8, Iss. 9
Open Access | Times Cited: 1
Recapitulating the adenoma–carcinoma sequence by selection of four spontaneous oncogenic mutations in mismatch-repair-deficient human colon organoids
Tomohiro Mizutani, Matteo Boretto, Sangho Lim, et al.
Nature Cancer (2024)
Open Access | Times Cited: 1
Hepatoblastoma exhibits a predominantly myeloid immune landscape and reveals opportunities for macrophage targeted immunotherapy
Daniëlle Krijgsman, Lianne J. Kraaier, Meggy E.L. Verdonschot, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Mutation accumulation in mtDNA of cancers resembles mutagenesis in normal stem cells
Freek Manders, Jip T. van Dinter, Ruben van Boxtel
iScience (2022) Vol. 25, Iss. 12, pp. 105610-105610
Open Access | Times Cited: 3
Pediatric therapy-related hematologic neoplasms show enrichment for KMT2A rearrangement and lymphoblastic phenotype
Alexandra E. Kovach, Daria Komova, Albert Itov, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 12, pp. 1840-1852
Closed Access
Antineoplastic therapy affects the in vitro phenotype and functionality of healthy human bone marrow-derived mesenchymal stromal cells
Bo Scherer, Lucienne Bogun, Annemarie Koch, et al.
Archives of Toxicology (2024) Vol. 99, Iss. 1, pp. 393-406
Open Access
Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies
Benjamin Diamond, Dhanvantri Chahar, Michael D. Jain, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Navigating Treatment‐Induced Head and Neck Malignancies in Cancer Survivors
Fábio Muradás Girardi, Gustavo Guthmann Pesenatto, Larissa Dill Fuchs, et al.
Oral Diseases (2024)
Closed Access
Evaluating offspring Genomic and Epigenomic alterations after prenatal exposure to Cancer treatment In Pregnancy (GE-CIP): a multicentric observational study
Ilana Struys, Carolina Velázquez, Koenraad Devriendt, et al.
BMJ Open (2024) Vol. 14, Iss. 3, pp. e081833-e081833
Open Access
Compound-dependent fetal toxicity after in utero exposure to chemotherapy in a pregnant mouse model
Ilana Struys, Ji‐Ying Song, Carolina Velázquez, et al.
Environmental Toxicology and Pharmacology (2024) Vol. 112, pp. 104594-104594
Closed Access
Childhood Cancer Treatment and Clonal Hematopoiesis
Grace Collord, Sam Behjati
Cancer Discovery (2023) Vol. 13, Iss. 4, pp. 811-813
Closed Access | Times Cited: 1
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA
Ugo Testa, Germana Castelli, Elvira Pelosi
Mediterranean Journal of Hematology and Infectious Diseases (2023) Vol. 15, Iss. 1, pp. e2023038-e2023038
Open Access | Times Cited: 1
The development of therapy related myeloid neoplasms in childhood cancer survivors
Esther A. Obeng, Tanja A. Grüber
Trends in cancer (2022) Vol. 8, Iss. 10, pp. 790-791
Closed Access | Times Cited: 1
Patterns of somatic mutations in normal cells
Freek Martijn Manders
(2023)
Open Access
Therapy-selected clonal hematopoiesis and its role in myeloid neoplasms
Jacob Jahn, Benjamin Diamond, Jeffrey Hsu, et al.
Leukemia Research (2023) Vol. 126, pp. 107020-107020
Open Access
Page 1

Scroll to top